Goločorbin-Kon, Svetlana
Type
Fulltext
Results 1-4 of 4 (Search time: 0.002 seconds).
| Issue Date | Title | Author(s) | |
|---|---|---|---|
| 1 | 1-Jan-2007 | Bioavailability and hypoglycemic activity of the semisynthetic bile acid salt, sodium 3α,7α-dihydroxy-12-oxo-5β-cholanate, in healthy and diabetic rats | Momir Mikov ; Boni N.; Al-Salami H.; Ksenija Kuhajda; Slavko Kevresšan; Svetlana Goločorbin-Kon ; Fawcett J. |
| 2 | 1-Jan-2009 | Cefotaxime pharmacokinetics after oral application in the form of 3α,7α-dihydroxy-12-keto-5β-cholanate microvesicles in rat | Svetlana Goločorbin-Kon ; Momir Mikov ; Arafat M.; Žika Lepojević; Ivan Mikov ; Sahman-Zaimovic M.; Zdenko Tomić |
| 3 | 1-Jan-2008 | The influence of 3α,7α-dihydroxy-12-keto-5β-cholanate on gliclazide pharmacokinetics and glucose levels in a rat model of diabetes | Momir Mikov ; Hani Al-Salami; Svetlana Goločorbin-Kon ; Ranko Škrbić; Aleksandar Rašković ; Paul J. Fawcett |
| 4 | 1-Apr-2009 | Lamotrigine and valproate pharmacokinetics interactions in epileptic patients | Mladena Lalić-Popović ; Jelena Helen Hogervorst ; Jovan Popović; Ksenija Božić; Svetlana Goločorbin-Kon ; Hani Al-Salami; Momir Mikov |